FDA expands use of Pfizer?s best-selling pneumonia vaccine
 

FDA expands use of Pfizer?s best-selling pneumonia vaccine
(Reuters) - Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Js:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Js:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/QhDqnIdLRpw